OSAIC HOLDINGS, INC. - HEPION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$36,898
+269.0%
47,524
+41.0%
0.00%
Q4 2022$10,000
-37.5%
33,701
+8.4%
0.00%
Q3 2022$16,000
+14.3%
31,093
+25.5%
0.00%
Q2 2022$14,000
-51.7%
24,766
+7.7%
0.00%
Q1 2022$29,000
+11.5%
22,989
-1.7%
0.00%
Q4 2021$26,000
+4.0%
23,389
+40.9%
0.00%
Q3 2021$25,000
-28.6%
16,604
-6.5%
0.00%
Q2 2021$35,000
+105.9%
17,751
+94.9%
0.00%
Q1 2021$17,000
+112.5%
9,109
+153.4%
0.00%
Q4 2020$8,0000.0%3,595
+43.7%
0.00%
Q3 2020$8,000
+166.7%
2,501
+149.9%
0.00%
Q2 2020$3,0001,001
+100000.0%
0.00%
Q1 2020$010.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 51,989$79,543,0000.24%
ASSET MANAGEMENT CORP /IL/ /ADV 133,500$204,0000.10%
Ikarian Capital, LLC 553,273$847,0000.06%
McAdam, LLC 55,978$86,0000.01%
JGP Wealth Management, LLC 15,000$23,0000.01%
Prospera Financial Services Inc 30,300$46,0000.00%
Fort Point Capital Partners LLC 10,000$15,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 55,599$85,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 6,501$10,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,800$76,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders